arbekacin and Sensitivity and Specificity

arbekacin has been researched along with Sensitivity and Specificity in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
LaPlante, KL; Rybak, MJ	1
Chow, JW; Kariyama, R; Kumon, H; You, I; Zervos, MJ	1

Other Studies

2 other study(ies) available for arbekacin and Sensitivity and Specificity

Article	Year
Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecycline. Diagnostic microbiology and infectious disease, 2004, Volume: 50, Issue:2 Topics: Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Daptomycin; Dibekacin; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Minocycline; Probability; Sampling Studies; Sensitivity and Specificity; Staphylococcus; Tigecycline; Vancomycin	2004
In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus. Diagnostic microbiology and infectious disease, 2000, Volume: 36, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Dibekacin; DNA, Bacterial; Drug Interactions; Drug Resistance, Multiple; Drug Therapy, Combination; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sensitivity and Specificity; Staphylococcus aureus; Vancomycin	2000

Article

Year

Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecycline.

Diagnostic microbiology and infectious disease, 2004, Volume: 50, Issue:2

Topics: Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Daptomycin; Dibekacin; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Minocycline; Probability; Sampling Studies; Sensitivity and Specificity; Staphylococcus; Tigecycline; Vancomycin

2004

In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus.

Diagnostic microbiology and infectious disease, 2000, Volume: 36, Issue:1

Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Dibekacin; DNA, Bacterial; Drug Interactions; Drug Resistance, Multiple; Drug Therapy, Combination; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sensitivity and Specificity; Staphylococcus aureus; Vancomycin

2000